Search

everythinglearnresearchcommunity

for

Search:↓

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Green tea extract may help reduce excessive hair growth.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Platelet-rich plasma with a new carrier significantly increases hair thickness without serious side effects.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Green tea may help with health issues like cancer, heart disease, and weight loss due to its high catechin content.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Acne lesions start with changes in hair follicles and increase in inflammation, suggesting a cycle that could affect treatment strategies.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.